-
Nippon India Pharma Fund Reinvestment Inc Dist cum Cap Wdrl
Equity healthcare
Overview ( as on 08/01/25 )
NAV
₹133.46
Last change
₹-1.43 -0.01%
Fund Size (AUM)
8914.89 Cr
Performance
31.07% (5Y)
Fund Details
Nippon India Pharma Fund Reinvestment Inc Dist cum Cap Wdrl
as of 08/01/25
AUM
8914.89 Cr
Expense Ratio
1.81 %
Benchmark
BSE Healthcare TR INR
ISIN
INF204K01943
Fund Manager
Sailesh Raj Bhan
Exit Load
1.0% if redeemed within 0-1 months
0% if redeemed after 1 months
| Fund Performance | 1Y | 3Y | 5Y |
|---|---|---|---|
| Nippon India Pharma Fund Reinvestment Inc Dist cum Cap Wdrl | 29.71% | 21.63% | 31.07% |
| BSE Healthcare TR INR | 43.51% | 19.99% | 27.52% |
Top 10 Holdings
Sun Pharmaceuticals Industries Ltd |
13.87% |
Divi's Laboratories Ltd |
9.24% |
Lupin Ltd |
8.47% |
Dr Reddy's Laboratories Ltd |
5.7% |
Cipla Ltd |
5.32% |
Apollo Hospitals Enterprise Ltd |
5.31% |
Vijaya Diagnostic Centre Ltd |
3.59% |
Medplus Health Services Ltd |
3.32% |
Ajanta Pharma Ltd |
3.16% |
Gland Pharma Ltd |
2.99% |
Sector Allocation
Healthcare |
100.0% |
Asset Allocation
-
98%
Equity
-
2%
Others
-
0%
Debt
Risk and Return Category
Risk v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Return v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Related Funds
-
ICICI Pru Pharma Healthcare Diag Gr
Equity healthcare-
Returns
-
31.03% (5Y)
-
-
SBI Healthcare Opportunities Reg Gr
Equity healthcare-
Returns
-
30.04% (5Y)
-
-
SBI Healthcare Opportunities Reg IDCW-R
Equity healthcare-
Returns
-
30.04% (5Y)
-
-
ICICI Pru Pharma Healthcare Dg IDCW-R
Equity healthcare-
Returns
-
28.16% (5Y)
-
-
DSP Healthcare Fund Reg Gr
Equity healthcare-
Returns
-
30.82% (5Y)
-
-
Nippon India Pharma IDCW-P
Equity healthcare-
Returns
-
31.07% (5Y)
-
